Publications by authors named "Omar Odat"

Claim this Profile
K
KS18, a Mcl-1 inhibitor, improves the effectiveness of bortezomib and overcomes resistance in refractory multiple myeloma by triggering intrinsic apoptosis.
Omar S Al-Odat, Weam Othman Elbezanti, Krishne Gowda, Sandeep K Srivastava, Shantu G Amin

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it possible to treat melanoma by intercepting the CXCR4/CXCL12 pathway?
Miriam Motlak, Meghna Mathews, Omar S Al-Odat, Manoj K Pandey

Cytokine· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between carpal height ratio and ulnar variance in normal wrist radiography.
Anas Ar Altamimi, Monther A Gharaibeh, Muntaser Abu Shokor, Moh'd S Dawod, Mohammad N Alswerki, Omar M Al-Odat

BMC Musculoskelet Disord· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients.
Omar S Al-Odat, Emily Nelson, Tulin Budak-Alpdogan, Subash C Jonnalagadda, Dhimant Desai

Cancers (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells.
Kuntal Bhowmick, Max von Suskil, Omar S Al-Odat, Weam Othman Elbezanti, Subash C Jonnalagadda

Heliyon· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma.
Omar S Al-Odat, Daniel A Guirguis, Nicole K Schmalbach, Gabriella Yao, Tulin Budak-Alpdogan

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells.
Weam Othman Elbezanti, Omar S Al-Odat, Robert Chitren, Jaikee Kumar Singh, Sandeep Kumar Srivastava

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.
Omar Al-Odat, Max von Suskil, Robert Chitren, Weam Elbezanti, Sandeep Srivastava

Front Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Max Von Suskil, Kazi Nasrin Sultana, Weam Othman Elbezanti, Omar S Al-Odat, Robert Chitren

Int J Mol Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
Osama Alshoubaki, Ziad Al Darabaa, Omar Odat, Ashraf Qubbaj, Ramzi Alhyari

Med Arch· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis